The DOI matches its Crossref record; 137 of the 142 references it cites were found in a registry or an index.
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
Open accessAbstract
There is now abundant evidence that brain microglia, when activated, have the lineage, receptors, and synthetic capacity to participate in both potentially neurotoxic inflammatory responses and potentially beneficial phagocytic responses. Amyloid beta peptide (Abeta) forms highly insoluble, beta-pleated aggregates that are widely deposited in the Alzheimer's disease (AD) cortex and limbic system. Aggregated Abeta also activates the classical and alternative complement cascades. These properties make Abeta an excellent target for microglial phagocytosis, a view supported by multiple reports, through well established mechanisms of phagocyte clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In AD, these cells can promote the clearance of Aβ, however, if they are not able to do that, there is an accumulation of Aβ deposits leading to neuronal death (Rogers et al., 2002).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Rogers et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,571
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Alternatively, certain NSAIDs may either decrease A formation or promote A clearance, or both (Lee and Wurtman, 2000; Lim et al., 2000; Blasko et al., 2001; Weggen et al., 2001).”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298
Flagged first, then by citations
5 of the 142 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Abbas A, 1994, Cellular and molecular immunology, 295
- 10.1084/jem.188.3.431 · DOI
- 10.1016/S0272-6386(12)80488-4 · DOI
- 10.1021/bi015685 · DOI
- Kovelowski CJ, 2001, Opsonization and anti‐inflammatory drug effects on microglial chemotaxis, phagocytosis, and cytokine secretion in vitro after amyloid peptide exposure, Soc Neurosci Abstr
- Lue LF, 1997, Modeling Aβ deposition in cultures of Alzheimer's glia and hnt neurons, Neurosci Abs, 23, 533
- 10.1002/glia.1072 · DOI
- 10.1073/pnas.89.21.10016 · DOI · Paper page
- 10.1002/jnr.490400407 · DOI
Cited by
Sorted by citations
Items 201–300 of 382
Function and Comorbidities of Apolipoprotein E in Alzheimer′s Disease
Leduc, V., Domenger, D., Beaumont, L. D., Lalonde, D., Jasmin, S. B., & Poirier, J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/974361 · Cited by 46
Microglia and Other Myeloid Cells in Central Nervous System Health and Disease
Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 42
Synaptotagmin‐11 inhibits cytokine secretion and phagocytosis in microglia
Du, C., Wang, Y., Zhang, F., Yan, S., Guan, Y., Gong, X., Zhang, T., Cui, X., Wang, X., & Zhang, C. X. (2017) · Glia · doi:10.1002/glia.23186 · Cited by 44
Toward Alzheimer Therapies Based on Genetic Knowledge
Hardy, J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103607 · Cited by 42
Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
Grieco, M., Caris, M. G. D., Maggi, E., Armeli, F., Coccurello, R., Bisogno, T., D’Erme, M., Maccarrone, M., Mancini, P., & Businaro, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147711 · Cited by 39
The role of neuroinflammation in cerebral amyloid angiopathy
van den Brink, H., Voigt, S., Kozberg, M., & van Etten, E. S. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105466 · Cited by 39
Zhao, Y., Cui, J.-G., & Lukiw, W. J. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:181 · Cited by 38
Goswami, P., Afjal, M. A., Akhter, J., Mangla, A., Khan, J., Parvez, S., & Raisuddin, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.09.022 · Cited by 39
Mok, S. W.-F., Wong, V. K. W., Lo, H. H., Dias, I. R. D. S. R., Leung, E. L., Law, B. Y. K., & Liu, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107480 · Cited by 39
Cheng, S., Zhang, C., Xu, C., Wang, L., Zou, X., & Chen, G. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.029 · Cited by 39
Lv, J., Ma, S., Zhang, X., Zheng, L., Ma, Y., Zhao, X., Lai, W., Shen, H., Wang, Q., & Ji, J. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.07.028 · Cited by 38
HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.
(2008) · PubMed Central · Cited by 37
Shie, F., Montine, K. S., BREYER, R. M., & Montine, T. J. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00509.x · Cited by 37
Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model
Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 39
Burbach, G. J., Dehn, D., Turco, D. D., Staufenbiel, M., & Deller, T. (2004) · Glia · doi:10.1002/glia.20057 · Cited by 36
Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach
Candore, G., Balistreri, C. R., Grimaldi, M. P., Listı̀, F., Vasto, S., Chiappelli, M., Licastro, F., Colonna‐Romano, G., Lio, D., & Caruso, C. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.013 · Cited by 37
Chen, K., Zhang, L., Huang, J., Gong, W., Dunlop, N. M., & Wang, J. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907607 · Cited by 36
Ramírez, G., Rey, S., & Rommy von Bernhardi, M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15104 · Cited by 36
Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36
Dickkopf‐related protein 3 is a potential Aβ‐associated protein in Alzheimer's Disease
Bruggink, K. A., Kuiperij, H. B., Gloerich, J., Otte‐Höller, I., Rozemüller, A. J. M., Claassen, J. A. H. R., Küsters, B., & Verbeek, M. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13216 · Cited by 35
Uptake of Aβ 1–40- and Aβ 1–42-coated yeast by microglial cells: a role for LRP
Laporte, V., Lombard, Y., Levy-Benezra, R., Tranchant, C., Poindron, P., & Warter, J.-M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203620 · Cited by 27
Joo, S. S., & Lee, D. I. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02972981 · Cited by 34
Comparison of Vascular Perturbations in an A β ‐Injected Animal Model and in AD Brain
Jantaratnotai, N., Ryu, J. K., Schwab, C., McGeer, P. L., & McLarnon, J. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/918280 · Cited by 33
Salemi, J., Obregon, D. F., Cobb, A., Reed, S., Sadic, E., Jin, J., Fernandez, F., Tan, J., & Giunta, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-3 · Cited by 28
Schulte‐Herbrüggen, O., Eckart, S., Deicke, U., Kuhl, A. A., Otten, U., Danker‐Hopfe, H., Abramowski, D., Staufenbiel, M., & Hellweg, R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21704 · Cited by 34
Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer’s disease
Magga, J. M., Savchenko, E., Malm, T., Rõlova, T., Pollari, E., Valonen, P. K., Lehtonen, Š., Jantunen, E., Aarnio, J., Lehenkari, P. P., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01390.x · Cited by 33
Protein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 33
Xue, Q., Sparks, D. L., & Streit, W. J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-20 · Cited by 32
Feng, C., Yin, J., Yang, J., & Cao, L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.12.017 · Cited by 31
Kim, J. M., Lee, U., Kang, J. Y., Park, S. K., Shin, E. J., Kim, H., Kim, C. W., Kim, M.-J., & Heo, H. J. (2020) · Antioxidants · doi:10.3390/antiox9100976 · Cited by 30
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model
Oliveira, D. V., Coupland, K., Shao, W., Jin, S., Gaudio, F. D., Wang, S., Fox, R., Rutten, J. W., Sandin, J., Zetterberg, H., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216556 · Cited by 35
Prostaglandin E2 reduces amyloid β-induced phagocytosis in cultured rat microglia
Nagano, T., Kimura, S. H., & Takemura, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.086 · Cited by 30
Taming of macrophage and microglial cell activation by microRNA-124
Conrad, A., & Dittel, B. N. (2011) · Cell Research · doi:10.1038/cr.2011.9 · Cited by 29
Amyloid β peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
Ciaramella, A., Sanarico, N., Bizzoni, F., Moro, M. L., Salani, F., Scapigliati, G., Spalletta, G., Caltagirone, C., & Bossù, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.007 · Cited by 29
Yang, Y. J., Shiao, C., Hemingway, J. F., Jorstad, N. L., Shalloway, B. R., Chang, R. C., & Keene, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064246 · Cited by 29
Perturbed Signal Transduction in Neurodegenerative Disorders Involving Aberrant Protein Aggregation
Mattson, M. P., & Sherman, M. Y. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:109 · Cited by 29
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
Rommy von Bernhardi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1248 · Cited by 28
Interactions between GSK3β and amyloid genes explain variance in amyloid burden
Hohman, T. J., Koran, M. E. I., & Thornton‐Wells, T. A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.032 · Cited by 28
Diminished Production of Proinflammatory Cytokines in Patients with Alzheimer’s Disease
Richartz, E., Batra, A., Simon, P. D., Wormstall, H., Bartels, M., Buchkremer, G., & Schott, K. J. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000083497 · Cited by 29
Moon, M.-Y., Kim, H.-J., Li, Y., Kim, J.-G., Jeon, Y.-J., Won, H.-Y., Kim, J.-S., Kwon, H.-Y., Choi, I.-G., Ro, E., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.023 · Cited by 27
Steiner, L., Gold, M., Mengel, D., Dodel, R. C., & Bach, J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.032 · Cited by 27
Association between the Polymorphism of CCR5 and Alzheimer's Disease
Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listı̀, F., Chiappelli, M., Licastro, F., Lio, D., Caruso, C., & Candore, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.012 · Cited by 27
Dyne, E. D., Prakash, P. S., Li, J., Yu, B., Schmidt, T. L., Huang, S. D., & Kim, M. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102397 · Cited by 26
Bialowas‐McGoey, L. A., Lesicka, A., & Whitaker‐Azmitia, P. M. (2008) · Glia · doi:10.1002/glia.20727 · Cited by 25
Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain
Streit, W. J., Xue, Q., Braak, H., & Tredici, K. D. (2013) · Glia · doi:10.1002/glia.22589 · Cited by 24
Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Aβ42
Persaud‐Sawin, D., Banach, L., & Harry, G. J. (2008) · Glia · doi:10.1002/glia.20759 · Cited by 24
Microglia in amyotrophic lateral sclerosis.
Dewil, M., Bosch, L. V. D., & Robberecht, W. (2007) · PubMed · Cited by 24
Lattanzi, R., Maftei, D., Petrella, C., Pieri, M., Sancesario, G. M., Schirinzi, T., Bernardini, S., Barbato, C., Ralli, M., Greco, A., et al. (2019) · Cells · doi:10.3390/cells8111430 · Cited by 25
The Role of CNI-1493 in the Function of Primary Microglia with Respect to Amyloid-β
Bach, J., Mengel, D., Wahle, T., Kautz, A., Balzer‐Geldsetzer, M., Al‐Abed, Y., Dodel, R. C., & Bacher, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110179 · Cited by 23
Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
Kakkar, A., Singh, H., Singh, B. K., Kumar, A., Mishra, A. K., & Chopra, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374353 · Cited by 26
miRNAs Stem Cell Reprogramming for Neuronal Induction and Differentiation
Perruisseau-Carrier, C., Jurga, M., Forraz, N., & McGUCKIN, C. P. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8179-z · Cited by 22
CD14 receptor polymorphism and Alzheimer's disease risk
Combarros, O., Infante, J., Rodríguez‐Rodríguez, E., Llorca, J., Peña, N., Fernández‐Viadero, C., & Berciano, J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.082 · Cited by 22
Genetic discoveries and advances in late‐onset Alzheimer’s disease
Rezazadeh, M., Hosseinzadeh, H., Moradi, M., Esfahani, B. S., Talebian, S., Parvin, S., & Gharesouran, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28372 · Cited by 23
Freire‐Cobo, C., Rothwell, E. S., Varghese, M., Edwards, M. M., Janssen, W. G. M., Agnès Lacreuse, A., & Hof, P. R. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.001 · Cited by 21
Ding, L.-L., Chu, W., Xia, Y., Ming, S., Li, T., Zhou, F., & Deng, D. Y. B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06003-8 · Cited by 21
Therapeutic Potential of Neu1 in Alzheimer’s Disease Via the Immune System
Khan, A., Das, S. K., & Sergi, C. M. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317521996147 · Cited by 21
Early inhibition of TNFα increases 6-hydroxydopamine-induced striatal degeneration
Gemma, C., Catlow, B. J., Cole, M., Hudson, C., Samec, A. M., Shah, N. K., Vila, J., Bachstetter, A. D., & Bickford, P. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.003 · Cited by 21
“Olfactory Three-Needle” Enhances Spatial Learning and Memory Ability in SAMP8 Mice
Wang, Y., Wang, Q., Ren, B. X., Guo, T., Qiang, J., Cao, H., Gao, Y., Liu, Z., Gao, X., & Zhu, B. (2020) · Behavioural Neurology · doi:10.1155/2020/2893289 · Cited by 20
Association between dementia and systemic rheumatic disease: A nationwide population-based study
Park, H., Yim, D., Ochirpurev, B., Eom, S., Choi, I. A., Ju, G., & Kim, J. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248395 · Cited by 20
Quinlan, R. A., & Straughan, B. (2005) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2005.1483 · Cited by 19
cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities
Fazal, F., Dar, N. J., Ahamad, S., Khan, S., Bano, N., Saha, S., Nazir, A., & Bhat, S. A. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101444 · Cited by 21
Kageyama, Y., Saito, A., Pletniková, O., Rudow, G. L., Irie, Y., An, Y., Murakami, K., Irie, K., Resnick, S. M., Fowler, D. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35004-3 · Cited by 17
Early complement activation increases in the brain in some aged normal subjects
Loeffler, D. A., Camp, D. M., Schonberger, M. B., Singer, D. J., & LeWitt, P. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.003 · Cited by 18
Faridi, A., Yang, W. L., Kelly, H. G., Wang, C., Faridi, P., Purcell, A. W., Davis, T. P., Chen, P., Kent, S. J., & Ke, P. C. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01116 · Cited by 17
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
Yao, A. Y., Halloran, P. J., Ge, Y., Singh, N., Zhou, J., Galske, J., He, W., Yan, R., & Hu, X. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-22.2023 · Cited by 17
Guo, Q., Cheng, J., Zhang, J., Su, B., Bian, C., Lin, S., & Zhong, C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12175 · Cited by 17
Rosell‐Cardona, C., Griñán‐Ferré, C., Pérez‐Bosque, A., Polo, J., Pallàs, M., Amat, C., Moretó, M., & Miró, L. (2021) · Nutrients · doi:10.3390/nu13072369 · Cited by 17
Ebert, S., Goos, M., Rollwagen, L., Baake, D., Zech, W., Esselmann, H., Wiltfang, J., Mollenhauer, B., Schliebs, R., Gerber, J., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22270 · Cited by 17
Fröhlich, C., Paarmann, K., Steffen, J., Stenzel, J., Krohn, M., Heinze, H., & Pahnke, J. (2013) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.3.2013.1.3 · Cited by 17
Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis
Manocha, G. D., Puig, K. L., Austin, S. A., Seyb, K. I., Glicksman, M. A., & Combs, C. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132604 · Cited by 17
Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Smit, T., Ormel, P. R., Sluijs, J. A., Hulshof, L. A., Middeldorp, J., de Witte, L. D., Hol, E. M., & Donega, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.001 · Cited by 16
Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease
Zakharova, N. V., Kononikhin, A. S., Indeykina, M. I., Bugrova, A. E., Strelnikova, P. A., Игоревич, П. С., Kozin, S. A., Popov, I. A., Mitkevich, V. A., Makarov, A. А., et al. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21775 · Cited by 16
Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice
Khayer, N., Marashi, S., Mirzaie, M., & Goshadrou, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184697 · Cited by 16
Stahl, T., Reimers, C., Johne, R., Schliebs, R., & Seeger, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05069.x · Cited by 16
Tsay, H.-J., Huang, Y., Huang, F.-L., Chen, C.-P., Tsai, Y.-C., Wang, Y.-H., Wu, M.-F., Chiang, F.-Y., & Shiao, Y. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-78 · Cited by 16
Cellular Therapy Using Microglial Cells
Schloendorn, J., Sethe, S. C., & Stolzing, A. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.0511 · Cited by 15
Okura, Y., Kohyama, K., Park, I.-K., & Matsumoto, Y. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818b48db · Cited by 15
Kubis-Kubiak, A., Marcinkowska, E., Janusz, M., & Lisowski, J. (2005) · Peptides · doi:10.1016/j.peptides.2005.04.001 · Cited by 15
The implication of a diversity of non-neuronal cells in disorders affecting brain networks
Carrier, M., Dolhan, K., Bobotis, B. C., Desjardins, M., & Tremblay, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1015556 · Cited by 16
Wu, Y., Libby, J. B., Dumitrescu, L. C., Jager, P. L. D., Menon, V., Schneider, J. A., Bennett, D. A., & Hohman, T. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14419 · Cited by 15
Hojjati, S. H., Butler, T., de Leon, M. J., Gupta, A. K., Nayak, S., Luchsinger, J. A., Razlighi, Q. R., & Chiang, G. C.-Y. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.01.005 · Cited by 18
Ranganathan, R., Sapozhnikov, G., Wang, N., Li, S., & Song, Y. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.06.004 · Cited by 14
Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 14
The safety of Micro-implants for the brain
Dabbour, A.-H., Tan, S., Kim, S. H., Guild, S.-J., Heppner, P., McCormick, D., Wright, B. E., Leung, D., Gallichan, R., Budgett, D., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.796203 · Cited by 13
Transcriptome analysis of molecular mechanisms underlying facial nerve injury repair in rats
Shi, Y., Zhang, L., Cao, Q., Li, S., Lu, Y., Wu, D., & Feng, W. S. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310700 · Cited by 12
Njavro, J. R., Vukicevic, M., Fiorini, E., Dinkel, L., Müller, S. A., Berghofer, A., Bordier, C., Kozlov, S. O., Halle, A., Buschmann, K., et al. (2022) · Cells · doi:10.3390/cells12010079 · Cited by 13
How Microglia Manages Non-cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of AD
Seol, Y., Ki, S., Ryu, H. L., Chung, S., Lee, J.-H., & Ryu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.593724 · Cited by 12
Aging-induced alterations in microglial cells and their impact on neurodegenerative disorders
Singh, H., Gupta, R., Gupta, M., & Ahmad, A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10623-y · Cited by 11
Swanson, M. E. V., Mrkela, M., Turner, C. P., Curtis, M. A., Faull, R. L. M., Walker, A. K., & Scotter, E. L. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01941-0 · Cited by 14
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer’s Disease
Painuli, S., Semwal, P., Zam, W., Taheri, Y., Ezzat, S. M., Zuo, P., Li, L., Kumar, D., Sharifi‐Rad, J., & Martins, N. A. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220428112541 · Cited by 11
Alarcón‐Aguilar, A., González‐Puertos, V. Y., Luna‐López, A., López-Macay, Á., Morán, J., Santamarı́a, A., & Königsberg, M. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2841 · Cited by 11
Plant-based vaccines for Alzheimer's disease: an overview
Rosales‐Mendoza, S., Rubio‐Infante, N., Zarazúa, S., Govea‐Alonso, D. O., Martel‐Gallegos, G., & Moreno‐Fierros, L. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.874948 · Cited by 11
Cao, Y., Liu, J., Hu, C., Li, Y., Wang, X., & Yan, J. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135932 · Cited by 10
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10
Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease
Minné, D., Marnewick, J. L., & Engel-Hills, P. C. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230811092956 · Cited by 10
Interaction of microglia and amyloid-β through β2-integrin is regulated by RhoA
Jeon, Y.-J., Won, H.-Y., Moon, M., Choi, W., Chang, C.-H., Lee, J. Y., Kim, J., Kim, S.-C., Kim, Y.-S., & Park, J. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283140f10 · Cited by 10
Dual role of cofilin in APP trafficking and amyloid‐β clearance
Liu, T., Woo, J. A., Yan, Y., LePochat, P., Bukhari, M. Z., & Kang, D. E. (2019) · The FASEB Journal · doi:10.1096/fj.201901268r · Cited by 10
Proteomic Markers and Early Prediction of Alzheimer’s Disease
Zakharova, N. V., Bugrova, A. E., Indeykina, M. I., Fedorova, Y. B., Колыхалов, И. В., Si, G., Николаев, Е. Н., & Kononikhin, A. S. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922080089 · Cited by 7
Grenon, M. B., Papavergi, M.-T., Bathini, P., Sadowski, M. J., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115754 · Cited by 7
Metadata
- Authors
- Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R.
- Affiliations
- Banner Sun Health Research Institute (US)
- Corresponding author
- Rogers, Joseph
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-10-04
- Volume
- 40
- Issue
- 2
- Pages
- 260-269
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2046704592
- Cited by
- 381
- References
- 142
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 15 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 14 · 2014: 19 · 2013: 17 · 2012: 18
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Glia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institute on Aging (AGO7367)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- microglia, amyloid-beta, Alzheimer's disease, microglial phagocytosis, neuroinflammation, complement system, microglial activation
- MeSH terms
- Alzheimer Disease, Animals, Antigen-Antibody Complex, Antigens, Chemotaxis, Encephalitis, Humans, Phagocytosis, Amyloid beta-Peptides, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review